Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial
- PMID: 32938633
- PMCID: PMC7492823
- DOI: 10.1136/bmj.m3208
Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial
Abstract
Objective: To investigate whether opportunistic screening in primary care increases the detection of atrial fibrillation compared with usual care.
Design: Cluster randomised controlled trial.
Setting: 47 intention-to-screen and 49 usual care primary care practices in the Netherlands, not blinded for allocation; the study was carried out from September 2015 to August 2018.
Participants: In each practice, a fixed sample of 200 eligible patients, aged 65 or older, with no known history of atrial fibrillation in the electronic medical record system, were randomly selected. In the intention-to-screen group, 9218 patients eligible for screening were included, 55.0% women, mean age 75.2 years. In the usual care group, 9526 patients were eligible for screening, 54.3% women, mean age 75.0 years.
Interventions: Opportunistic screening (that is, screening in patients visiting their general practice) consisted of three index tests: pulse palpation, electronic blood pressure measurement with an atrial fibrillation algorithm, and electrocardiography (ECG) with a handheld single lead electrocardiographic device. The reference standard was 12 lead ECG, performed in patients with at least one positive index test and in a sample of patients (10%) with three negative tests. If 12 lead ECG showed no atrial fibrillation, patients were invited for more screening by continuous monitoring with a Holter electrocardiograph for two weeks.
Main outcome measures: Difference in the detection rate of newly diagnosed atrial fibrillation over one year in intention-to-screen versus usual care practices.
Results: Follow-up was complete for 8874 patients in the intention-to-screen practices and for 9102 patients in the usual care practices. 144 (1.62%) new diagnoses of atrial fibrillation in the intention-to-screen group versus 139 (1.53%) in the usual care group were found (adjusted odds ratio 1.06 (95% confidence interval 0.84 to 1.35)). Of 9218 eligible patients in the intention-to-screen group, 4106 (44.5%) participated in the screening protocol. In these patients, 12 lead ECG detected newly diagnosed atrial fibrillation in 26 patients (0.63%). In the 266 patients who continued with Holter monitoring, four more diagnoses of atrial fibrillation were found.
Conclusions: Opportunistic screening for atrial fibrillation in primary care patients, aged 65 and over, did not increase the detection rate of atrial fibrillation, which implies that opportunistic screening for atrial fibrillation is not useful in this setting.
Trial registration: Netherlands Trial Register No NL4776 (old NTR4914).
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the Netherlands Organisation for Health Research and Development and Amsterdam Universities Medical Centres for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Detection of atrial fibrillation in primary care with radial pulse palpation, electronic blood pressure measurement and handheld single-lead electrocardiography: a diagnostic accuracy study.BMJ Open. 2022 Jun 29;12(6):e059172. doi: 10.1136/bmjopen-2021-059172. BMJ Open. 2022. PMID: 35768092 Free PMC article. Clinical Trial.
-
Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial.Trials. 2015 Oct 23;16:478. doi: 10.1186/s13063-015-1006-5. Trials. 2015. PMID: 26499449 Free PMC article. Clinical Trial.
-
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.Health Technol Assess. 2005 Oct;9(40):iii-iv, ix-x, 1-74. doi: 10.3310/hta9400. Health Technol Assess. 2005. PMID: 16202350 Clinical Trial.
-
Effectiveness of systematic screening for the detection of atrial fibrillation.Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009586. doi: 10.1002/14651858.CD009586.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2016 Jun 03;(6):CD009586. doi: 10.1002/14651858.CD009586.pub3. PMID: 23633374 Updated. Review.
-
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2017 May;21(29):1-236. doi: 10.3310/hta21290. Health Technol Assess. 2017. PMID: 28629510 Review.
Cited by
-
Integrating Clinical, Genetic, and Electrocardiogram-Based Artificial Intelligence to Estimate Risk of Incident Atrial Fibrillation.medRxiv [Preprint]. 2024 Aug 14:2024.08.13.24311944. doi: 10.1101/2024.08.13.24311944. medRxiv. 2024. PMID: 39185529 Free PMC article. Preprint.
-
Screening and detection of atrial fibrillation in primary care: current practice and future perspectives.Eur Heart J Suppl. 2024 Jul 31;26(Suppl 4):iv12-iv18. doi: 10.1093/eurheartjsupp/suae074. eCollection 2024 Jul. Eur Heart J Suppl. 2024. PMID: 39099572 Free PMC article.
-
Innovative approaches to atrial fibrillation prediction: should polygenic scores and machine learning be implemented in clinical practice?Europace. 2024 Aug 3;26(8):euae201. doi: 10.1093/europace/euae201. Europace. 2024. PMID: 39073570 Free PMC article. Review.
-
Automated interpretations of single-lead electrocardiograms predict incident atrial fibrillation: The VITAL-AF trial.Heart Rhythm. 2024 Sep;21(9):1640-1646. doi: 10.1016/j.hrthm.2024.04.085. Epub 2024 Apr 29. Heart Rhythm. 2024. PMID: 38692342 Clinical Trial.
-
Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial.BMJ Open. 2024 Apr 25;14(4):e082047. doi: 10.1136/bmjopen-2023-082047. BMJ Open. 2024. PMID: 38670614 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical